
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3D60926518733C3D60003A37B433.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontonco">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Oncology">
<meta name="citation_title" content="Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model">
<meta name="citation_author" content="Jacopo Azzollini">
<meta name="citation_author_institution" content="Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Andrea Vingiani">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author_institution" content="Oncology and Hemato-oncology Department, University of Milan, Milan, Italy">
<meta name="citation_author" content="Luca Agnelli">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author_institution" content="Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Elena Tamborini">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Federica Perrone">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Elena Conca">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Iolanda Capone">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Adele Busico">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Bernard Peissel">
<meta name="citation_author_institution" content="Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Erica Rosina">
<meta name="citation_author_institution" content="Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Monika Ducceschi">
<meta name="citation_author_institution" content="Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Mara Mantiero">
<meta name="citation_author_institution" content="Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Salvatore Lopez">
<meta name="citation_author_institution" content="Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Francesco Raspagliesi">
<meta name="citation_author_institution" content="Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Monica Niger">
<meta name="citation_author_institution" content="Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Matteo Duca">
<meta name="citation_author_institution" content="Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Silvia Damian">
<meta name="citation_author_institution" content="Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Claudia Proto">
<meta name="citation_author_institution" content="Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Filippo de Braud">
<meta name="citation_author_institution" content="Oncology and Hemato-oncology Department, University of Milan, Milan, Italy">
<meta name="citation_author_institution" content="Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author" content="Giancarlo Pruneri">
<meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_author_institution" content="Oncology and Hemato-oncology Department, University of Milan, Milan, Italy">
<meta name="citation_author" content="Siranoush Manoukian">
<meta name="citation_author_institution" content="Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy">
<meta name="citation_publication_date" content="2022 Apr 8">
<meta name="citation_volume" content="12">
<meta name="citation_firstpage" content="857515">
<meta name="citation_doi" content="10.3389/fonc.2022.857515">
<meta name="citation_pmid" content="35463374">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/pdf/fonc-12-857515.pdf">
<meta name="description" content="Tumour testing of the BRCA1/2 genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under ...">
<meta name="og:title" content="Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Tumour testing of the BRCA1/2 genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9026437">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fonc.2022.857515"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fonc-12-857515.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9026437%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9026437/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9026437/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontonco.gif" alt="Frontiers in Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Oncology" title="Link to Frontiers in Oncology" shape="default" href="http://www.frontiersin.org/oncology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Oncol</button></div>. 2022 Apr 8;12:857515. doi: <a href="https://doi.org/10.3389/fonc.2022.857515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fonc.2022.857515</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Azzollini%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jacopo Azzollini</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jacopo Azzollini</span></h3>
<div class="p">
<sup>1</sup>
Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Azzollini%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jacopo Azzollini</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vingiani%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Andrea Vingiani</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Andrea Vingiani</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">
<sup>3</sup>
Oncology and Hemato-oncology Department, University of Milan, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vingiani%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrea Vingiani</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Agnelli%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Luca Agnelli</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Luca Agnelli</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Agnelli%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luca Agnelli</span></a>
</div>
</div>
<sup>2,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tamborini%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Elena Tamborini</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Elena Tamborini</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tamborini%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Tamborini</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Perrone%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Federica Perrone</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Federica Perrone</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Perrone%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Federica Perrone</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Conca%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Elena Conca</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Elena Conca</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Conca%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Conca</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Capone%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Iolanda Capone</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Iolanda Capone</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Capone%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Iolanda Capone</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Busico%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Adele Busico</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Adele Busico</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Busico%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Adele Busico</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peissel%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Bernard Peissel</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Bernard Peissel</span></h3>
<div class="p">
<sup>1</sup>
Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peissel%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bernard Peissel</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rosina%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Erica Rosina</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Erica Rosina</span></h3>
<div class="p">
<sup>1</sup>
Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rosina%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Erica Rosina</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ducceschi%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Monika Ducceschi</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Monika Ducceschi</span></h3>
<div class="p">
<sup>5</sup>
Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ducceschi%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Monika Ducceschi</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mantiero%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Mara Mantiero</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Mara Mantiero</span></h3>
<div class="p">
<sup>5</sup>
Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mantiero%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mara Mantiero</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lopez%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Salvatore Lopez</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Salvatore Lopez</span></h3>
<div class="p">
<sup>5</sup>
Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lopez%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Salvatore Lopez</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raspagliesi%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Francesco Raspagliesi</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Francesco Raspagliesi</span></h3>
<div class="p">
<sup>5</sup>
Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raspagliesi%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesco Raspagliesi</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Niger%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Monica Niger</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Monica Niger</span></h3>
<div class="p">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Niger%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Monica Niger</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duca%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Matteo Duca</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Matteo Duca</span></h3>
<div class="p">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duca%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Matteo Duca</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Damian%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Silvia Damian</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Silvia Damian</span></h3>
<div class="p">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Damian%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Silvia Damian</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Proto%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Claudia Proto</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Claudia Proto</span></h3>
<div class="p">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Proto%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudia Proto</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Braud%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Filippo de Braud</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Filippo de Braud</span></h3>
<div class="p">
<sup>3</sup>
Oncology and Hemato-oncology Department, University of Milan, Milan, Italy
</div>
<div class="p">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Braud%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Filippo de Braud</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pruneri%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Giancarlo Pruneri</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Giancarlo Pruneri</span></h3>
<div class="p">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">
<sup>3</sup>
Oncology and Hemato-oncology Department, University of Milan, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pruneri%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giancarlo Pruneri</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>â€ </sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manoukian%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Siranoush Manoukian</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Siranoush Manoukian</span></h3>
<div class="p">
<sup>1</sup>
Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manoukian%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Siranoush Manoukian</span></a>
</div>
</div>
<sup>1,</sup><sup>*,</sup><sup>â€ </sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div id="aff2">
<sup>2</sup>
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div id="aff3">
<sup>3</sup>
Oncology and Hemato-oncology Department, University of Milan, Milan, Italy
</div>
<div id="aff4">
<sup>4</sup>
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div id="aff5">
<sup>5</sup>
Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Ian Campbell, Peter MacCallum Cancer Centre, Australia</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Sanjeevani Arora, Fox Chase Cancer Center, United States; Raymond H. Kim, University of Toronto, Canada</p></div>
<div class="fn" id="fn001">
<sup>âœ‰</sup><p class="display-inline">*Correspondence: Siranoush Manoukian, <span>siranoush.manoukian@istitutotumori.mi.it</span>
</p>
</div>
<div class="fn" id="fn003"><p>â€ These authors share last authorship</p></div>
<div class="fn" id="fn002"><p>This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Jan 18; Accepted 2022 Mar 17; Collection date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright Â© 2022 Azzollini, Vingiani, Agnelli, Tamborini, Perrone, Conca, Capone, Busico, Peissel, Rosina, Ducceschi, Mantiero, Lopez, Raspagliesi, Niger, Duca, Damian, Proto, de Braud, Pruneri and Manoukian</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9026437Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35463374/" class="usa-link">35463374</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Tumour testing of the <em>BRCA1/2</em> genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under investigation. This study aims at evaluating the performance of the tumour-to-germline diagnostic flowchart model defined at our Institutional Molecular Tumour Board (MTB). Results from tumour BRCA sequencing of 641 consecutive unselected cancer patients were discussed during weekly MTB meetings with the early involvement of clinical geneticists for appropriate referral to genetic counselling. The overall tumour detection rate of <em>BRCA1/2</em> PVs was 8.7% (56/641), ranging from 24.4% (31/127) in high-grade ovarian cancer to 3.9% (12/304) in tumours not associated with germline <em>BRCA1/2</em> PVs. Thirty-seven patients with PVs (66%) were evaluated by a clinical geneticist, and in 24 of them (64.9%), germline testing confirmed the presence of the PV in blood. Nine of these patients (37.5%) were not eligible for germline testing according to the criteria in use at our institution. Cascade testing was subsequently performed on 18 relatives. The tumour-to-germline diagnostic pipeline, developed in the framework of our institutional MTB, compared with guideline-based germline testing following genetic counselling, proved to be effective in identifying a higher number of germline BRCA PVs carriers.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> ovarian cancer, homologous recombination, HBOC (hereditary breast and ovarian cancer), genetic counselling, BRCA1, BRCA2, somatic variants</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Genomic analysis of tumour DNA is mandatory for both the pathological diagnosis and the selection of patients who may benefit from drugs targeting specific gene aberrations (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>, <a href="#B2" class="usa-link" aria-describedby="B2">2</a>). In the last years, next-generation sequencing (NGS) techniques for tumour testing is increasingly used as a clinical tool to simultaneously analyze hundreds of genes in different cancer settings (<a href="#B3" class="usa-link" aria-describedby="B3">3</a>â€“<a href="#B5" class="usa-link" aria-describedby="B5">5</a>). ThisÂ approach fostered the acquisition of a massive amount of tumour molecular data and increased the detection of variants in cancer-predisposing genes. These identified in tumours, although not necessarily actionable in terms of therapeutic targeting, might be of germline origin and thus particularly relevant to address tumour risks in patients and their relatives (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>â€“<a href="#B8" class="usa-link" aria-describedby="B8">8</a>).</p>
<p>Among high-penetrance cancer-predisposing genes, pathogenic variants of <em>BRCA1</em> and <em>BRCA2</em> are the most frequent germline alterations found at tumour testing and represent the most common incidental germline finding in unselected populations of cancer-affected individuals (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>â€“<a href="#B11" class="usa-link" aria-describedby="B11">11</a>). Different approaches have been proposed to identify carriers of germline variants among individuals undergoing tumour testing, including parallel tumour and germline analysis (parallel testing) or upfront tumour sequencing followed by germline testing in selected cases (tumour-to-germline testing) (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>â€“<a href="#B14" class="usa-link" aria-describedby="B14">14</a>). Data on the diagnostic pipeline, particularly in the Italian population, are currently scarce and mostly limited to OC patients (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>, <a href="#B15" class="usa-link" aria-describedby="B15">15</a>â€“<a href="#B17" class="usa-link" aria-describedby="B17">17</a>).</p>
<p>Herein we present the results of a tumour-to-germline model of BRCA testing developed by an Institutional Molecular Tumour Board (MTB) in a large Italian cohort of consecutive patients with different cancer histotypes, providing data on its impact on genetic counselling and cascade testing in family members.</p></section><section id="s2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Patients Cohort</h3>
<p>The study cohort was selected among consecutive cancer-affected individuals who underwent genetic testing on tumour DNA for therapeutic purposes, regardless of the type of cancer, age at diagnosis and family history. We included in the analysis only patients discussed at the Molecular Tumour Board (MTB) of the Fondazione IRCCS Istituto Nazionale dei tumori of Milan (INT) between April 29<sup>th</sup> 2020 and June 30<sup>th</sup> 2021, and for whom successful complete sequencing of the <em>BRCA1</em> and <em>BRCA2</em> genes in the tumour was available. Patients in the final cohort were either affected with tumours associated with BRCA defects, which might be eligible for treatment with PARP inhibitors (PARPi), or developed tumours with indications for treatments targeting different molecular pathways. Genetic testing in the first group was carried out mainly with NGS of only the BRCA genes, while in the second group the analysis was performed through a larger gene panel.</p></section><section id="s2_2"><h3 class="pmc_sec_title">Tissue Preparation and Tumour Sequencing</h3>
<p>In 185 out of 641 patients, mostly affected with ovarian cancer, tumour variants of the <em>BRCA1</em> and <em>BRCA2</em> genes were assessed by in-house NGS testing using the Oncomine BRCA Research Assay (Thermo Fisher Scientific, Inc). This assay provided a 100% coverage of all <em>BRCA1</em> and <em>BRCA2</em> exons, with an average of 64 bases of intronic flanking sequences upstream and downstream of each exon. Five Âµm sections from formalin-fixed paraffin-embedded (FFPE) samples were manually microdissected to isolate the highest percentage of neoplastic cells. Genomic DNA was extracted with protease K (incubation ON at 55Â°C) and quantified with Qubit dsDNA BR kit (Thermo Fisher Scientific, Inc).</p>
<p>The libraries were prepared with the IonAmpliSeq Library kit 2.0 (Thermo Fisher Scientific, Inc) and quantified with Qubit dsDNA HS kit (Thermo Fisher Scientific, Inc) following the manufacturerâ€™s instructions. The libraries are diluted to 25 pm, pooled and loaded on the Ion Chef to perform emulsion PCR and chip loading, using Ion 318 v2 Chip and ION PGM HI-Q view Chef kit, according to the manufacturerâ€™s instructions.</p>
<p>Data were processed using the Torrent Suite. Variant calling from sequencing data was generated by the Variant Caller plugin. To eliminate erroneous base calling, we set each variant coverage &gt;40, a variant frequency on each sample &gt;5 and a quality value &gt;30. The resulting variants were annotated using the Ensemble Variant Effect Predictor pipeline, Ion Reporter analysis software. Each variant is displayed on IGV2.11.1. Among the called variants, synonymous variants are filtered out and other variants are classified into pathogenicity classes according to the Evidence-based Network for the Interpretation of Mutant Alleles (ENIGMA) consortium guidelines (<a href="https://enigmaconsortium.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org/</a>). This assay could not reliably detect large intragenic rearrangements.</p>
<p>The other 456 patients were mainly affected with tumours for which PARPi are not indicated, but other therapeutic options targeting different genes and molecular pathways are available. This group underwent quantitative NGS on tumour FFPE slide specimens using the validated Foundation One CDx assay (Foundation Medicine, Cambridge, MA), which detects nucleotide substitutions, small insertions/deletions and copy number alterations in 324 genes (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). This assay provided also an estimate of the tumour mutational burden (TMB) in 364 samples.</p></section><section id="s2_3"><h3 class="pmc_sec_title">Molecular Tumour Board Workflow</h3>
<p>The MTB, composed of pathologists, oncologists, molecular biologists, bioinformatics and clinical geneticists, performed a weekly evaluation of the molecular analyses, interpreted and classified the identified genetic variants and provided recommendations on therapeutic targets and the appropriateness of genetic counselling and additional genetic testing. In case pathogenic or likely pathogenic <em>BRCA1/BRCA2</em> variants (henceforth termed PVs), as defined according to the ENIGMA criteria, were identified, clinicians were advised by the clinical geneticists of the MTB to refer the patients to genetic counselling for targeted germline testing. Information about clinical or family features suggestive of Hereditary Breast and Ovarian Cancer syndrome (HBOC) were reviewed by the clinical geneticists in all patients affected with a BRCA-associated tumour. Since the Oncomine BRCA assay does not detect large rearrangements, all patients, who tested negative at this assay yet fulfilled the empirical selection criteria for BRCA germline testing used at our Institution (<a href="#SM1" class="usa-link">
<strong>Supplementary TableÂ 1</strong>
</a>) (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>), were referred to genetic counselling and were offered the germline analysis of large rearrangements involving the <em>BRCA1</em>/<em>2</em> genes (<a href="#f1" class="usa-link">
<strong>FigureÂ 1</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">FigureÂ 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9026437_fonc-12-857515-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf9/9026437/678b816c34b1/fonc-12-857515-g001.jpg" loading="lazy" height="799" width="708" alt="FigureÂ 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Workflow of the management of BRCA tumour testing results with potential germline implications. MTB, Molecular Tumour Board; GC, genetic counselling; PVs, pathogenic/likely pathogenic variants.</p></figcaption></figure><p>If a PV was confirmed to be germline, the probands were informed about the opportunity of genetic counselling and cascade testing in family members.</p>
<p>In case PVs affecting actionable genes other than <em>BRCA1</em> and <em>BRCA2</em> were identified at the Foundation One CDx assay, genetic counselling and germline testing were offered according to the ESMO Precision Medicine Working Group recommendations (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>).</p>
<p>The Local Ethics committee approved the use of both clinical and molecular data collected by the MTB for clinical studies and granted exemption from requiring written consent for tumour genetic testing from the patients, as these analyses were conducted in a routine diagnostic and care setting (approval number INT 227/20). All the probands and relatives who underwent germline testing were aged over 18 and provided signed informed consent for the use of their biological samples and data for both diagnostic and research purposes. The consent form was in use at our Institution and was previously approved by the INT Ethics committee (INT 171/15).</p></section><section id="s2_4"><h3 class="pmc_sec_title">Germline Testing</h3>
<p>Two EDTA tubes of peripheral blood samples were collected from each patient who performed genetic counselling and was eligible for germline testing. Whole blood DNA was isolated through the MagCore<sup>Â®</sup> Super automatic workstation with the MagCore<sup>Â®</sup> Genomic DNA Whole Blood Kit (Diatech LabLine SRL, Jesi, Italy).</p>
<p>Targeted Sanger sequencing of tumour-detected <em>BRCA1/BRCA2</em> PVs was performed on purified PCR products by using BigDye<sup>Â®</sup> Terminator v.3.1 Cycle Sequencing kit (Thermo Fisher Scientific, Inc.) and run on 3730Xl DNA Analyzer (Applied Biosystems; Thermo Fisher Scientific, Inc.), after purification with Agencourt CleanSeq<sup>Â®</sup>-Beckman Coulter. Sequences were analyzed by Mutation Surveyor<sup>Â®</sup> Software (v5.0.1; SoftGenetics, LLC., State College, PA, USA). Targeted sequencing results were confirmed on both blood aliquots collected from each patient. Variants of uncertain clinical significance identified at tumour testing were not systematically investigated at the germline level.</p>
<p>Eligible probands, who resulted negative at tumour testing with the Oncomine BRCA assay, were analysed for large deletions and duplications of <em>BRCA1</em> and <em>BRCA2</em> on blood DNA with the SALSA MLPA kits P045 <em>BRCA2</em>/<em>CHEK2</em> and P002 <em>BRCA1</em> probe mix (MRC-Holland, Amsterdam, the Netherlands), following the manufacturerâ€™s instructions. MLPA products were run on the 3730Xl DNA Analyzer (Applied Biosystems; Thermo Fisher Scientific, Inc.) with the Gene Mapper Module (Applied Biosystems; Thermo Fisher Scientific, Inc.). The results were analyzed through the Gene Marker Software v2.7.0 (SoftGenetics, LLC, State College, PA, USA).</p></section><section id="s2_5"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>Descriptive statistics and confidence intervals of the mean were used for reporting the age at tumour testing of the patients. The two-tailed Fisherâ€™s exact test was employed to compare the frequency of BRCA PVs in different tumour types. An unpaired <em>t-</em>test was used to compare the age at diagnosis of OC between patients with germline versus somatic only BRCA PVs. One-sided Mann Whitney test for unpaired data was used to compare the tumour mutational burden (TMB) values between BRCA wild-type tumours and tumours with BRCA PVs and to compare the allele frequency of germline versus somatic only PVs.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3_1"><h3 class="pmc_sec_title">Patients</h3>
<p>The study population was represented by all the patients consecutively analyzed by NGS and discussed by the Institutional Molecular Tumour Board between April the 29<sup>th</sup>, 2020 and June the 30<sup>th</sup>, 2021. Overall, 1549 patients were evaluated, including 840 females and 709 males, with a median age at tumour testing of 64 years (range 0 â€“ 90 years). Tumour sequencing of all coding exons of the <em>BRCA1</em> and <em>BRCA2</em> genes was carried out in 641 (41.3%) cases, including patients with ovarian (OC, 154, 24%), biliopancreatic (BPC, 135, 21.1%), breast (BC, 36, 5.6%) and prostate (PC, 12, 1.9%) cancer, as well as other tumours not typically associated with BRCA1/2 PVs, including gastrointestinal (GI) tumours (147, 22.9%) and other histotypes (157, 24.5%). The histology of OC patient tumours was high-grade serous (HGSOC, 112 cases), high-grade non-serous (HGOC, 15 cases) and low grade or unknown/uncertain type (27 cases) carcinoma. Out of the 641 patients tested for BRCA, 185 (128 of which were OC) were analysed using the Oncomine BRCA Research Assay, and the remaining 456 (26 OCs, 25 BCs, 106 BPCs, 5 PCs, 146 GI tumours, and 148 other tumours), using the Foundation One CDx assay.</p></section><section id="s3_2"><h3 class="pmc_sec_title">BRCA Tumour Testing Results</h3>
<p>Out of 641 patients analyzed, 56 (8.7%, 20 in <em>BRCA1</em> and 36 in <em>BRCA2</em>) bore tumour BRCA PVs and 64 variants of uncertain significance (VUS). All the PVs were small truncating variants, except two large deletions at BRCA2, representing large intragenic rearrangement, which were both detected using the Foundation One assay. A complete list of the detected PVs is available in <a href="#SM2" class="usa-link">
<strong>Supplementary TableÂ 2</strong>
</a>.</p>
<p>The detection rate of PVs (DR) in the whole cohort was 8.7% (56/641). A wide range of DRs was found across the histotypes analysed: 20.8% in OC patients (32/154, 16 <em>BRCA1</em> and 16 <em>BRCA2</em>, rising to 24.4% in HGOCs), 11.1% in BC patients (4/36, 2 <em>BRCA1</em> and 2 <em>BRCA2</em>), 4.4% in BPC patients (6/135, <em>BRCA2</em>), 16.7% in PC patients (2/12, <em>BRCA2</em>), 4.8% in GI tumour patients (7/147, 2 <em>BRCA1</em> and 5 <em>BRCA2</em>), and 3.2% in patients with other tumours (5/157, <em>BRCA2</em>) (<a href="#f2" class="usa-link">
<strong>FigureÂ 2</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">FigureÂ 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf9/9026437/933fae5b7bcc/fonc-12-857515-g002.jpg" loading="lazy" height="448" width="787" alt="FigureÂ 2"></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Detection rate of BRCA pathogenic/likely pathogenic variants (PVs) at tumour testing in different primary tumours.</p></figcaption></figure><p>As expected, the DR in OCs was significantly higher compared with all other tumour types considered together (<em>p&lt;0.0001</em>). Due to the limited number of BCs and prostate cancers in our cohort, we could not detect a significant difference in the DR in these compared with other tumours. Notably, in BPC the DR was not different compared with tumours not in the spectrum of HBOC.</p>
<p>The tumour mutational burden (TMB) was available in 364 of the 456 cases analysed, including 23 tumours with BRCA PVs, and it was significantly higher in BRCA mutated (median 7.57 mut/Mb) than wild-type tumours (median 3.78 mut/Mb) (<em>p&lt;0.005</em>) (<a href="#f3" class="usa-link">
<strong>FigureÂ 3</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">FigureÂ 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf9/9026437/15a4d3977d1f/fonc-12-857515-g003.jpg" loading="lazy" height="568" width="590" alt="FigureÂ 3"></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Boxplots of the Tumour Mutational Burden (TMB) in BRCA wild-type tumours (left) and tumours with BRCA pathogenic/likely pathogenic variants (PVs) (right); extreme outliers (TMB &gt;30 mut/Mb) are not displayed.</p></figcaption></figure></section><section id="s3_3"><h3 class="pmc_sec_title">Referral to Genetic Counselling and Germline Testing Results</h3>
<p>Seven out of the 56 patients with a PV in the tumour had previously undergone germline testing following a clinical geneticist evaluation, and five of them yielded consistent results. In one of the two OC patients with discordant results, the c.1813delA PV, located at a homopolymeric region of <em>BRCA2</em>, was not detected by the Oncomine variant calling software. Nevertheless, a subsequent manual curation analysis with IGV tools allowed us to demonstrate that the variant was occurring in the tumour as well. In the other patient, bearing the germline <em>BRCA2</em> c.4284dupT p.(Gln1429Serfs*9) variant, tumour testing on relapsing OC tissue showed the large <em>BRCA2</em> deletion p.(Leu1334_Asn1742del) encompassing the germline variant. This patient showed a clinical progression upon platinum and PARPi treatment, suggesting the occurrence of a resistance reverse mutation at the tumour level.</p>
<p>Thirty out of the 56 patients with PVs detected by tumour testing were subsequently evaluated by a clinical geneticist and underwent targeted germline testing (<a href="#f4" class="usa-link">
<strong>FigureÂ 4</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f4"><h4 class="obj_head">FigureÂ 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9026437_fonc-12-857515-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf9/9026437/cf71773b9064/fonc-12-857515-g004.jpg" loading="lazy" height="497" width="763" alt="FigureÂ 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flowchart of tumour and germline BRCA testing results in the whole cohort. VUS, variants of uncertain significance; GC, genetic counselling; PVs, pathogenic/likely pathogenic variants.</p></figcaption></figure><p>In 19 patients (15 OC, and one each BPC, duodenal cancer, PC and urothelial cancer patients), the PV was confirmed to be germline. Nine of these 19 patients (47.4%) would not have been eligible for germline testing based on the clinical criteria in use at our Institution. With regards to OC patients, 33.3% of germline carriers (5/15) would not have been tested if the tumour sequencing had not been performed frontline. Conversely, of the 30 patients who underwent germline analysis, 11 (36.7%) had somatic only PVs, and nine (81.9%) of them would not have been eligible for germline testing. In the OC patient subgroup with a BRCA PV in the tumour, 28.6% (6/21) of the PVs were not detected at germline testing (<a href="#f5" class="usa-link">
<strong>FigureÂ 5</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f5"><h4 class="obj_head">FigureÂ 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf9/9026437/15a4d822c010/fonc-12-857515-g005.jpg" loading="lazy" height="436" width="787" alt="FigureÂ 5"></p>
<div class="p text-right font-secondary"><a href="figure/f5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Ratio of somatic only vs. germline BRCA pathogenic/likely pathogenic variants (PVs), according to the primary tumour type, in 30 patients who underwent both tumour and germline testing.</p></figcaption></figure><p>Age at diagnosis of OC in patients with germline PVs was lower than in patients with somatic only PVs (53 vs 57.5 years), although the difference did not achieve statistical significance (<a href="#SF1" class="usa-link">
<strong>Supplementary FigureÂ 1</strong>
</a>). Median PV allele frequency, available in 23 cases, was 0.69 (range 0.39-0.94) for germline variants and 0.19 (range 0.07-0.61) for somatic variants (<em>p&lt;0,001</em>). Although mutational tumour burden data were available for eight patients with germline PVs only, no difference was observed between BRCA-mutated and wild-type tumours (median 3.78 mut/Mb, <em>p=n.s.</em>).</p>
<p>Nineteen of the 56 patients bearing tumour BRCA PVs did not perform genetic counselling at our Institution due to different reasons, including loss at follow-up, death or severe health condition, or refusal to perform germline testing. No further BRCA aberrations were detected by Multiplex Ligation-dependent Probe Amplification (MLPA) in 22 patients (18 OC and 4 BC patients) eligible for germline testing due to personal or family history but testing negative at the Oncomine BRCA assay (<a href="#f4" class="usa-link">
<strong>FigureÂ 4</strong>
</a>).</p></section><section id="s3_4"><h3 class="pmc_sec_title">Genetic Counselling and Germline Testing in Family Members</h3>
<p>Following the identification of a BRCA germline PV in 19 probands, we offered genetic counselling and cascade testing to family members. As of the 31<sup>st</sup> October 2021, 18 individuals from eight families (11 females, 7 males), with a median age of 55 years (range 33-77 years), performed targeted germline testing, and ten were found to have inherited the family variant (<a href="#f6" class="usa-link">
<strong>FigureÂ 6</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f6"><h4 class="obj_head">FigureÂ 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9026437_fonc-12-857515-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf9/9026437/8e33fdfd92d0/fonc-12-857515-g006.jpg" loading="lazy" height="451" width="669" alt="FigureÂ 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/f6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Targeted analysis of BRCA pathogenic/likely pathogenic variants (PVs) in family members of carriers identified through tumour testing.</p></figcaption></figure><p>Nine of these carriers reported a negative personal oncological history at the time of counselling, while one had developed colon cancer at 64 years. Among the eight non-carriers, two reported a personal history of cancer, one with bilateral BC at the age of 52 (right side) and 53 years (left side), the other with a testicular embryonal carcinoma at the age of 26 years. Nine (50%) of the 18 tested family members, including seven carriers, belonged to three families, which would have not been eligible for germline testing according to institutional clinical criteria.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Therapies targeting homologous recombination defects (HRD) are steadily adopted in different cancer settings, yielding a higher volume of BRCA tumour testing carried out in pathology labs. Recently, the updated <em>post-hoc</em> analysis of progression-free survival from SOLO1 trial in germline and somatic BRCA mutated advanced OC patients reported after 5 years of follow-up a median progression-free survival of 56.0 months with olaparib versus 13.8 months with placebo (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>).</p>
<p>Along this line, several trials are ongoing for addressing whether, in addition to germline PVs, somatic BRCA mutations may also be predictive of PARPi efficacy in several cancer settings. The identification of BRCA as an actionable target for personalized therapy revolutionized its testing workflow, which was traditionally preceded by genetic counselling, and significantly increased the volume of patients analyzed (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>, <a href="#B23" class="usa-link" aria-describedby="B23">23</a>)</p>
<p>In this complex scenario, BRCA testing is recommended to be managed by a multidisciplinary team of professionals, including clinical geneticists, that takes care of variant annotation, clinical trial recruitment and potential association with germline variants. In this study, we reported from a clinical geneticist perspective the BRCA diagnostic flowchart implemented by our Institutional MTB in an Italian cohort of 641 cancer patients genomically profiled by targeted NGS.</p>
<p>In the time frame of the study, 641 tumours underwent full sequencing of the BRCA genes. About one-fifth of these were OCs, which were mostly analysed with the Oncomine BRCA assay (83%, 128/154). Conversely, most other tumours underwent sequencing with the larger Foundation One multigene panel (88%, 430/487). The latter group included also tumours for which PARPi are not indicated, but other therapeutic options targeting different molecular defects are available.</p>
<p>In accordance with previous data, the frequency of tumour BRCA PVs was roughly 20% in OC (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>, <a href="#B24" class="usa-link" aria-describedby="B24">24</a>â€“<a href="#B27" class="usa-link" aria-describedby="B27">27</a>) and 4% in BPC (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). Notably, in our cohort, the DR in BPC was not different compared with tumours not in the spectrum of HBOC, possibly due to the relatively small number of patients investigated. However, it has been proposed that outside OC and BC settings, a higher fraction of BRCA PVs might represent an incidental finding, without a causal connection to tumour pathogenesis. This hypothesis is supported by the study by Yost et al, who reported a low frequency of both PVs and loss-of-heterozygosity (LOH) events involving the BRCA genes in tumours other than OC and BC (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>).</p>
<p>In our model, targeted germline testing is offered whenever a BRCA PV is identified in the tumour, irrespective of the histological subtype, allele frequency and TMB. Although an allele frequency close to or higher than 50% could point to a germline origin of the variant (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>, <a href="#B20" class="usa-link" aria-describedby="B20">20</a>), as confirmed in our series, multiple factors may affect its estimate, including tumour cellularity, copy-number variation (CNV) and LOH, as well as sequencing and variant calling methods used for the tumour analysis (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>, <a href="#B29" class="usa-link" aria-describedby="B29">29</a>). A high TMB is another feature that could be associated with BRCA PVs. As previously reported for several cancer types (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>, <a href="#B30" class="usa-link" aria-describedby="B30">30</a>, <a href="#B31" class="usa-link" aria-describedby="B31">31</a>), BRCA PVs in our cohort were associated with a higher TMB. However, our data on the TMB in germline carriers are limited and do not allow us to explore putative differences between germline and somatic only PVs.</p>
<p>A relevant aspect of all the diagnostic flowcharts is represented by the actual concordance between tumour and germline testing. Previous studies evidenced discrepancies between these analyses, mainly due to the low sensitivity in detecting large rearrangements from highly fragmented DNA obtained from FFPE tissues. In a cohort of high-grade epithelial OC patients, Chandrasekaran and colleagues recently reported a 1,4% discordant rate in detecting large rearrangements, due to tumour testing failure (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>), thus suggesting performing concurrent/parallel tumour and germline analysis would be preferable. However, other studies showed that the prevalence of large BRCA rearrangements in other tumour types seems to be lower than that observed in OCs. In a large cohort from the US, Sharder etÂ al. identified 52 carriers of BRCA PVs and only two large BRCA deletions among 1566 patients with advanced neoplasms (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>). This finding was subsequently confirmed by Mendelker and colleagues, who reported 59 carriers of BRCA PVs and only one individual with a deletion, affecting exon 8 of <em>BRCA1</em>, among 1040 germline analyses of patients with unselected advanced cancers (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>). In addition, the parallel tumour and germline approach, besides being less affordable in terms of costs, has also the disadvantage of waiving the choice of whether or not to undergo predictive germline testing. In our cohort, almost one-third of patients in whom a BRCA PV had been identified in the tumour, despite being referred to genetic counselling, were lost to follow up. A subset of these did not desire to know their germline status. Another potential limit could be to generate additional anxiety in patients whose main focus is the treatment of the present tumour rather than future risks for themselves or their relatives.</p>
<p>Other authors proposed a tumour-to-germline approach based on tumour sequencing up front, followed by targeted germline testing in selected patients. A recent study provided evidence that discussing molecular results of tumour testing within a MTB including clinical geneticists improved both the referral to genetic counselling and the identification of germline PVs (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>). In our tumour-to-germline flowchart, all the molecular results along with clinical and familial data of patients with negative tumour testing are reviewed by clinical geneticists. All the patients eligible for germline testing are offered an MLPA analysis when the techniques used for tumour sequencing were inadequate for detecting large rearrangements. In this regard, out of the 22 patients with wild-type tumour BRCA analyzed by MLPA, no one showed gene rearrangement. Overall, only one large rearrangement was detected in 181 patients with tumours in the spectrum HBOC (including BC, OC, BPC and PC), suggesting that the probability of overlooking these molecular defects is seemingly low also in our series.</p>
<p>However, there are limitations in the use of tumour testing for guiding germline analyses. In our series, one patient previously found to be a carrier of a germline <em>BRCA2</em> PV was negative at tumour testing, likely since it was located in a homopolymeric region, which is usually inefficiently sequenced by Ion torrent-based techniques. However, the frequency and impact of this phenomenon have not yet been determined (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>â€“<a href="#B34" class="usa-link" aria-describedby="B34">34</a>).</p>
<p>An additional potential flaw of tumour testing is represented by the detection of reverse mutation. In an OC patient with acquired resistance to both platinum salts and PARPi, we found an in-frame deletion of 409 codons affecting BRCA2 exon 11 in tissue obtained from relapse. A former analysis had revealed a germline pathogenic <em>BRCA2</em> point variant within the same region of the somatically deleted allele, allowing to classify the deletion as a reverse mutation. In this case, if a complete germline analysis had not been performed, the tumour testing result would have been misinterpreted, with a potentially negative impact on the patientâ€™s treatment. Furthermore, the germline variant would not have been recognized, with consequences on both the patient and her relatives. Although this phenomenon has been consistently reported in BRCA-related tumours (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>, <a href="#B36" class="usa-link" aria-describedby="B36">36</a>), its occurrence is uncommon in untreated primary cancers, suggesting that testing for targetable BRCA PVs should be carried out in the most recent specimen available. Finally, it has to be underlined that reverse mutations might mask underlying germline PVs when tumour testing is carried out in tumours previously exposed to cytotoxic agents, which might have selected clones with reverse mutations conferring drug resistance.</p>
<p>Collectively, these data suggest that the risk of missing BRCA PVs with a tumour-to-germline approach would be limited. In addition, also parallel tumour and germline testing would still overlook a fraction of either somatic or germline pathogenic alterations, such as epigenetic events (<a href="#B37" class="usa-link" aria-describedby="B37">37</a>â€“<a href="#B39" class="usa-link" aria-describedby="B39">39</a>).</p>
<p>Using our tumour-to-germline diagnostic flowchart, we identified an additional 50% of germline carriers. In particular, 9 out of 19 germline carriers of BRCA PVs would not have been eligible for germline testing according to the institutional criteria based on personal or family history. Interestingly, the frequency of these incremental germline PVs in our cohort is in line with that reported by Samadder and colleagues in a recent study, which compared universal germline testing of cancer affected individuals versus guideline-directed targeted testing (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>). On this basis, it could be argued that universal germline testing could be proposed as an alternative screening method to the herein presented tumour-to-germline diagnostic flowchart. However, albeit it is seemingly as effective in identifying germline carriers, this approach would overlook a considerable fraction of patients with PVs confined to the tumour, who might still benefit from cancer-specific targeted therapies (e.g. PARPi in OC).</p>
<p>Although our model has the overt advantage of identifying a higher number of individuals at increased genetic risk, it has also generated some concerns in our clinical practice. By the end of October 2021, an equal number of relatives from families eligible and non-eligible for germline testing, based on the empirical criteria in use at our Institution, underwent genetic counselling and targeted testing. However, in some patients with anamnestic features not suggestive of a genetic predisposition, we experienced more pronounced distress and lower acceptance of a positive test result, which might, in turn, lead to lower compliance with the recommended preventive measures. Moreover, indications on both screening and risk-reducing surgery are currently provided considering risk estimates calculated on high-risk families (i.e. with multiple affected individuals). Recent population-based case-control studies demonstrated that the penetrance of BRCA PVs is lower in unselected cohorts (<a href="#B40" class="usa-link" aria-describedby="B40">40</a>, <a href="#B41" class="usa-link" aria-describedby="B41">41</a>), likely due to the influence of polygenic inheritance in certain families, with multiple susceptibility loci that modify the penetrance of BRCA PVs (<a href="#B42" class="usa-link" aria-describedby="B42">42</a>). Consequently, there is a potential risk of â€œovertreatmentâ€, due to an overestimation of the risks in patients and relatives from non-eligible families. Obtaining more accurate and tailored penetrance estimates based on larger cohorts and population-specific studies will be critical, along with the future inclusion of personal polygenic risk scores in a diagnostic setting.</p>
<p>To the best of our knowledge, this is the first study to describe a model in which all the tumour testing results are reviewed by the MTB with the early involvement of clinical geneticists. The presence of oncogenetics experts in the early phases enhanced the annotation and interpretation of suspected germline variants. Moreover, compared with the â€œmainstreamed genetic testingâ€ strategy, it allowed a more direct and prompt referral to genetic counselling for both patients with PVs and individuals who should undergo further germline investigations irrespective of the tumour testing results. Since this approach proved to be feasible and effective in the management of HBOC patients, we expect it to be readily applied also to other cancer-predisposing syndromes.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>The herein discussed model and diagnostic flowchart of our Institutional MTB proved to be effective in identifying a higher number of germline carriers of BRCA PVs compared with guideline-based germline testing following genetic counselling. Since most targeted therapies are approved only for patients with germline PVs, assessing the germline status is mandatory for guiding treatment. However, our data highlight that, compared with parallel tumour and germline testing, an approach based on tumour sequencing upfront with the early involvement of clinical geneticists is feasible to enhance the identification of germline carriers without increasing the burden on genetic counselling services.</p>
<p>Overall, we also observed good compliance of both patients and clinicians involved in their medical management. Moreover, this model promoted interdisciplinary discussion, which is of paramount importance to enhance precision healthcare for patients and their families. The collection of data on a larger cohort of patients will provide further insight into our observations and better address points of improvement of the presented model.</p></section><section id="s6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The studies involving human participants were reviewed and approved by Ethics committee of the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Written informed consent for participation was not provided by the participantsâ€™ legal guardians/next of kin because: The Ethics committee of the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (INT) approved the use of both clinical and molecular data collected by the MTB for clinical studies and granted exemption from requiring written consent for tumour genetic testing from the patients, as these analyses were conducted in a routine diagnostic and care setting (approval number INT 227/20). All the probands and relatives who underwent germline testing were aged over 18 and provided signed informed consent for the use of their biological samples and data for both diagnostic and research purposes. The consent form was in use at our Institution and was previously approved by the INT Ethics committee (INT 171/15).</p></section><section id="s8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Study concept and design: SM, GP. Acquisition of data: JA, AV, ET, FP, EC, IC, AB, BP, ER, MoD, MM, SL, FR, MN, MaD, SD, CP, FB, GP and SM. Analysis and interpretation of data: JA, ER and SM. Drafting of the manuscript: JA, SM. Critical revision of the manuscript for important intellectual content: All authors. Study supervision: SM, FB and GP. The authors read and approved the final version of the manuscript.</p></section><section id="s9"><h2 class="pmc_sec_title">Funding</h2>
<p>Roche Italia SpA, INT protocol 277/20, to GP for the setup of the institutional molecular tumour board platform. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.</p></section><section id="s10"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>FB: Consultant Advisory Board: Roche, EMD Serono, NMS Nerviano Medical Science, Sanofi, MSD, Novartis, Incyte, BMS, Menarini. Speaker: BMS, Healthcare Research &amp; Pharmacoepidemiology, Merck Group, ACCMED, Nadirex, MSD, Pfizer, Servier, Sanofi, Roche, AMGEN, Incyte, Dephaforum. Principal Investigator for Novartis, F.Hoffmann-LaRoche Ltd, BMS, Ignyta Operating INC, Merck Sharp &amp; Dohme Spa, Kymab, Pfizer, Tesaro, MSD, MedImmune LCC, Exelixis Inc., LOXO Oncology Incorporated, DAICHI SANKIO Dev. Limited, Basilea Pharmaceutica International AG, Janssen-Cilag International NV, Merck KGAA MN: Travel expenses from Celgene, speaker honorarium from Accademia della Medicina and consultant honoraria from EMD Serono, Basilea Pharmaceutica, Incyte and MSD Italia.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s11"><h2 class="pmc_sec_title">Publisherâ€™s Note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="s12"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fonc.2022.857515/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fonc.2022.857515/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SF1"><div class="caption p">
<span>Supplementary FigureÂ 1</span><p>Age at diagnosis of ovarian cancer in patients with confirmed germline vs. somatic only BRCA pathogenic/likely pathogenic variants (PVs). The median age is indicated by the horizontal lines; eligibility to germline testing according to the empirical criteria used at our Institution is indicated for eachÂ patient.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9026437/bin/Image_1.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (167.3KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/9026437/bin/Table_1.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (12KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM2"><div class="media p"><div class="caption">
<a href="/articles/instance/9026437/bin/Table_2.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (12.6KB, xlsx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Marchetti A, Barbareschi M, Barberis M, Buglioni S, Buttitta F, Fassan M, et al. Real-World Data on NGS Diagnostics: A Survey From the Italian Society of Pathology (SIAPeC) NGS Network. Pathologica (2021) 113:262â€“71. doi: 10.32074/1591-951X-324
</cite> [<a href="https://doi.org/10.32074/1591-951X-324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8488986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34463674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathologica&amp;title=Real-World%20Data%20on%20NGS%20Diagnostics:%20A%20Survey%20From%20the%20Italian%20Society%20of%20Pathology%20(SIAPeC)%20NGS%20Network&amp;author=A%20Marchetti&amp;author=M%20Barbareschi&amp;author=M%20Barberis&amp;author=S%20Buglioni&amp;author=F%20Buttitta&amp;volume=113&amp;publication_year=2021&amp;pmid=34463674&amp;doi=10.32074/1591-951X-324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Aleksakhina SN, Imyanitov EN. Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives. Int J Mol Sci (2021) 22:10931. doi: 10.3390/ijms222010931
</cite> [<a href="https://doi.org/10.3390/ijms222010931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8536080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34681592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Cancer%20Therapy%20Guided%20by%20Mutation%20Tests:%20Current%20Status%20and%20Perspectives&amp;author=SN%20Aleksakhina&amp;author=EN%20Imyanitov&amp;volume=22&amp;publication_year=2021&amp;pages=10931&amp;pmid=34681592&amp;doi=10.3390/ijms222010931&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Horak P, FrÃ¶hling S, Glimm H. Integrating Next-Generation Sequencing Into Clinical Oncology: Strategies, Promises and Pitfalls. ESMO Open (2016) 1:e000094. doi: 10.1136/esmoopen-2016-000094
</cite> [<a href="https://doi.org/10.1136/esmoopen-2016-000094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5133384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27933214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESMO%20Open&amp;title=Integrating%20Next-Generation%20Sequencing%20Into%20Clinical%20Oncology:%20Strategies,%20Promises%20and%20Pitfalls&amp;author=P%20Horak&amp;author=S%20Fr%C3%B6hling&amp;author=H%20Glimm&amp;volume=1&amp;publication_year=2016&amp;pages=e000094&amp;pmid=27933214&amp;doi=10.1136/esmoopen-2016-000094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, et al. Mutational Landscape of Metastatic Cancer Revealed From Prospective Clinical Sequencing of 10,000 Patients. Nat Med (2017) 23:703â€“13. doi: 10.1038/nm.4333
</cite> [<a href="https://doi.org/10.1038/nm.4333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5461196/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28481359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Mutational%20Landscape%20of%20Metastatic%20Cancer%20Revealed%20From%20Prospective%20Clinical%20Sequencing%20of%2010,000%20Patients&amp;author=A%20Zehir&amp;author=R%20Benayed&amp;author=RH%20Shah&amp;author=A%20Syed&amp;author=S%20Middha&amp;volume=23&amp;publication_year=2017&amp;pmid=28481359&amp;doi=10.1038/nm.4333&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Hyman DM, Taylor BS, Baselga J. Implementing Genome-Driven Oncology. Cell (2017) 168:584â€“99. doi: 10.1016/j.cell.2016.12.015
</cite> [<a href="https://doi.org/10.1016/j.cell.2016.12.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5463457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28187282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Implementing%20Genome-Driven%20Oncology&amp;author=DM%20Hyman&amp;author=BS%20Taylor&amp;author=J%20Baselga&amp;volume=168&amp;publication_year=2017&amp;pmid=28187282&amp;doi=10.1016/j.cell.2016.12.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Seifert BA, Oâ€™Daniel JM, Amin K, Marchuk DS, Patel NM, Parker JS, et al. Germline Analysis From Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings. Clin Cancer Res (2016) 22:4087â€“94. doi: 10.1158/1078-0432.CCR-16-0015
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-0015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4987173/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27083775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Germline%20Analysis%20From%20Tumor-Germline%20Sequencing%20Dyads%20to%20Identify%20Clinically%20Actionable%20Secondary%20Findings&amp;author=BA%20Seifert&amp;author=JM%20O%E2%80%99Daniel&amp;author=K%20Amin&amp;author=DS%20Marchuk&amp;author=NM%20Patel&amp;volume=22&amp;publication_year=2016&amp;pmid=27083775&amp;doi=10.1158/1078-0432.CCR-16-0015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, et al. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. JAMA (2017) 318:825â€“35. doi: 10.1001/jama.2017.11137
</cite> [<a href="https://doi.org/10.1001/jama.2017.11137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5611881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28873162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Mutation%20Detection%20in%20Patients%20With%20Advanced%20Cancer%20by%20Universal%20Sequencing%20of%20Cancer-Related%20Genes%20in%20Tumor%20and%20Normal%20DNA%20vs%20Guideline-Based%20Germline%20Testing&amp;author=D%20Mandelker&amp;author=L%20Zhang&amp;author=Y%20Kemel&amp;author=ZK%20Stadler&amp;author=V%20Joseph&amp;volume=318&amp;publication_year=2017&amp;pmid=28873162&amp;doi=10.1001/jama.2017.11137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell (2018) 173:355â€“70. doi: 10.1016/j.cell.2018.03.039
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.03.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5949147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29625052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Pathogenic%20Germline%20Variants%20in%2010,389%20Adult%20Cancers&amp;author=KL%20Huang&amp;author=RJ%20Mashl&amp;author=Y%20Wu&amp;author=DI%20Ritter&amp;author=J%20Wang&amp;volume=173&amp;publication_year=2018&amp;pmid=29625052&amp;doi=10.1016/j.cell.2018.03.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Schrader KA, Cheng DT, Joseph V, Prasad M, Walsh M, Zehir A, et al. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. JAMA Oncol (2016) 2:104â€“11. doi: 10.1001/jamaoncol.2015.5208
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2015.5208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5477989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26556299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Germline%20Variants%20in%20Targeted%20Tumor%20Sequencing%20Using%20Matched%20Normal%20DNA&amp;author=KA%20Schrader&amp;author=DT%20Cheng&amp;author=V%20Joseph&amp;author=M%20Prasad&amp;author=M%20Walsh&amp;volume=2&amp;publication_year=2016&amp;pmid=26556299&amp;doi=10.1001/jamaoncol.2015.5208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Meric-Bernstam F, Brusco L, Daniels M, Wathoo C, Bailey AM, Strong L, et al. Incidental Germline Variants in 1000 Advanced Cancers on a Prospective Somatic Genomic Profiling Protocol. Ann Oncol (2016) 27:795â€“800. doi: 10.1093/annonc/mdw018
</cite> [<a href="https://doi.org/10.1093/annonc/mdw018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4843184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26787237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Incidental%20Germline%20Variants%20in%201000%20Advanced%20Cancers%20on%20a%20Prospective%20Somatic%20Genomic%20Profiling%20Protocol&amp;author=F%20Meric-Bernstam&amp;author=L%20Brusco&amp;author=M%20Daniels&amp;author=C%20Wathoo&amp;author=AM%20Bailey&amp;volume=27&amp;publication_year=2016&amp;pages=795-800&amp;pmid=26787237&amp;doi=10.1093/annonc/mdw018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, et al. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncol (2021) 7:230â€“7. doi: 10.1001/jamaoncol.2020.6252
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2020.6252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7600058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33126242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Comparison%20of%20Universal%20Genetic%20Testing%20vs%20Guideline-Directed%20Targeted%20Testing%20for%20Patients%20With%20Hereditary%20Cancer%20Syndrome&amp;author=NJ%20Samadder&amp;author=D%20Riegert-Johnson&amp;author=L%20Boardman&amp;author=D%20Rhodes&amp;author=M%20Wick&amp;volume=7&amp;publication_year=2021&amp;pmid=33126242&amp;doi=10.1001/jamaoncol.2020.6252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Klek S, Heald B, Milinovich A, Ni Y, Abraham J, Mahdi H, et al. Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study. JNCI Cancer Spectr (2020) 4:pkaa018. doi: 10.1093/jncics/pkaa018
</cite> [<a href="https://doi.org/10.1093/jncics/pkaa018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7306190/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32596633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JNCI%20Cancer%20Spectr&amp;title=Genetic%20Counseling%20and%20Germline%20Testing%20in%20the%20Era%20of%20Tumor%20Sequencing:%20A%20Cohort%20Study&amp;author=S%20Klek&amp;author=B%20Heald&amp;author=A%20Milinovich&amp;author=Y%20Ni&amp;author=J%20Abraham&amp;volume=4&amp;publication_year=2020&amp;pages=pkaa018&amp;pmid=32596633&amp;doi=10.1093/jncics/pkaa018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Chandrasekaran D, Sobocan M, Blyuss O, Miller RE, Evans O, Crusz SM, et al. Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study. Cancers (Basel) (2021) 13:4344. doi: 10.3390/cancers13174344
</cite> [<a href="https://doi.org/10.3390/cancers13174344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8431198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34503154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Implementation%20of%20Multigene%20Germline%20and%20Parallel%20Somatic%20Genetic%20Testing%20in%20Epithelial%20Ovarian%20Cancer:%20SIGNPOST%20Study&amp;author=D%20Chandrasekaran&amp;author=M%20Sobocan&amp;author=O%20Blyuss&amp;author=RE%20Miller&amp;author=O%20Evans&amp;volume=13&amp;publication_year=2021&amp;pages=4344&amp;pmid=34503154&amp;doi=10.3390/cancers13174344&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Liu YL, Stadler ZK. The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer. J Natl Compr Canc Netw (2021) 19:871â€“8. doi: 10.6004/jnccn.2021.7044
</cite> [<a href="https://doi.org/10.6004/jnccn.2021.7044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11123333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34340209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Compr%20Canc%20Netw&amp;title=The%20Future%20of%20Parallel%20Tumor%20and%20Germline%20Genetic%20Testing:%20Is%20There%20a%20Role%20for%20All%20Patients%20With%20Cancer&amp;author=YL%20Liu&amp;author=ZK%20Stadler&amp;volume=19&amp;publication_year=2021&amp;pmid=34340209&amp;doi=10.6004/jnccn.2021.7044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
de Jonge MM, Ruano D, van Eijk R, van der Stoep N, Nielsen M, Wijnen JT, et al. Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue. J Mol Diagn (2018) 20:600â€“11. doi: 10.1016/j.jmoldx.2018.05.005
</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2018.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29936257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Diagn&amp;title=Validation%20and%20Implementation%20of%20BRCA1/2%20Variant%20Screening%20in%20Ovarian%20Tumor%20Tissue&amp;author=MM%20de%20Jonge&amp;author=D%20Ruano&amp;author=R%20van%20Eijk&amp;author=N%20van%20der%20Stoep&amp;author=M%20Nielsen&amp;volume=20&amp;publication_year=2018&amp;pmid=29936257&amp;doi=10.1016/j.jmoldx.2018.05.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Rivera D, Paudice M, Gismondi V, Anselmi G, Vellone VG, Varesco L. Ligurian BRCA Working Group. Implementing NGS-Based BRCA Tumour Tissue Testing in FFPE Ovarian Carcinoma Specimens: Hints From a Real-Life Experience Within the Framework of Expert Recommendations. J Clin Pathol (2021) 74:596â€“603. doi: 10.1136/jclinpath-2020-206840
</cite> [<a href="https://doi.org/10.1136/jclinpath-2020-206840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32895300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Pathol&amp;title=Ligurian%20BRCA%20Working%20Group.%20Implementing%20NGS-Based%20BRCA%20Tumour%20Tissue%20Testing%20in%20FFPE%20Ovarian%20Carcinoma%20Specimens:%20Hints%20From%20a%20Real-Life%20Experience%20Within%20the%20Framework%20of%20Expert%20Recommendations&amp;author=D%20Rivera&amp;author=M%20Paudice&amp;author=V%20Gismondi&amp;author=G%20Anselmi&amp;author=VG%20Vellone&amp;volume=74&amp;publication_year=2021&amp;pages=596-603&amp;pmid=32895300&amp;doi=10.1136/jclinpath-2020-206840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Toss A, Piombino C, Tenedini E, Bologna A, Gasparini E, Tarantino V, et al. The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results From a Multicenter Cohort Study. Diagnostics (Basel) (2021) 11:565. doi: 10.3390/diagnostics11030565
</cite> [<a href="https://doi.org/10.3390/diagnostics11030565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8003908/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33801055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics%20(Basel)&amp;title=The%20Prognostic%20and%20Predictive%20Role%20of%20Somatic%20BRCA%20Mutations%20in%20Ovarian%20Cancer:%20Results%20From%20a%20Multicenter%20Cohort%20Study&amp;author=A%20Toss&amp;author=C%20Piombino&amp;author=E%20Tenedini&amp;author=A%20Bologna&amp;author=E%20Gasparini&amp;volume=11&amp;publication_year=2021&amp;pages=565&amp;pmid=33801055&amp;doi=10.3390/diagnostics11030565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Foundation Medicine: FoundationOne CDx. Available at: <a href="https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx</a> (Accessed 2nd December 2021).</cite>
</li>
<li id="B19">
<span class="label">19.</span><cite>
Azzollini J, Scuvera G, Bruno E, Pasanisi P, Zaffaroni D, Calvello M, et al. Mutation Detection Rates Associated With Specific Selection Criteria for BRCA1/2 Testing in 1854 High-Risk Families: A Monocentric Italian Study. Eur J Intern Med (2016) 32:65â€“71. doi: 10.1016/j.ejim.2016.03.010
</cite> [<a href="https://doi.org/10.1016/j.ejim.2016.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27062684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Intern%20Med&amp;title=Mutation%20Detection%20Rates%20Associated%20With%20Specific%20Selection%20Criteria%20for%20BRCA1/2%20Testing%20in%201854%20High-Risk%20Families:%20A%20Monocentric%20Italian%20Study&amp;author=J%20Azzollini&amp;author=G%20Scuvera&amp;author=E%20Bruno&amp;author=P%20Pasanisi&amp;author=D%20Zaffaroni&amp;volume=32&amp;publication_year=2016&amp;pages=65-71&amp;pmid=27062684&amp;doi=10.1016/j.ejim.2016.03.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Mandelker D, Donoghue M, Talukdar S, Bandlamudi C, Srinivasan P, Vivek M, et al. Germline-Focussed Analysis of Tumour-Only Sequencing: Recommendations From the ESMO Precision Medicine Working Group. Ann Oncol (2019) 30:1221â€“31. doi: 10.1093/annonc/mdz136
</cite> [<a href="https://doi.org/10.1093/annonc/mdz136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6683854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31050713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Germline-Focussed%20Analysis%20of%20Tumour-Only%20Sequencing:%20Recommendations%20From%20the%20ESMO%20Precision%20Medicine%20Working%20Group&amp;author=D%20Mandelker&amp;author=M%20Donoghue&amp;author=S%20Talukdar&amp;author=C%20Bandlamudi&amp;author=P%20Srinivasan&amp;volume=30&amp;publication_year=2019&amp;pmid=31050713&amp;doi=10.1093/annonc/mdz136&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Banerjee S, Moore KN, Colombo N, Scambia G, Kim BG, Oaknin A, et al. Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation (SOLO1/GOG 3004): 5-Year Follow-Up of a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet Oncol (2021) 22:1721â€“31. doi: 10.1016/S1470-2045(21)00531-3
</cite> [<a href="https://doi.org/10.1016/S1470-2045(21)00531-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34715071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Maintenance%20Olaparib%20for%20Patients%20With%20Newly%20Diagnosed%20Advanced%20Ovarian%20Cancer%20and%20a%20BRCA%20Mutation%20(SOLO1/GOG%203004):%205-Year%20Follow-Up%20of%20a%20Randomised,%20Double-Blind,%20Placebo-Controlled,%20Phase%203%20Trial&amp;author=S%20Banerjee&amp;author=KN%20Moore&amp;author=N%20Colombo&amp;author=G%20Scambia&amp;author=BG%20Kim&amp;volume=22&amp;publication_year=2021&amp;pmid=34715071&amp;doi=10.1016/S1470-2045(21)00531-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E, et al. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer. JAMA Netw Open (2019) 2:e194428. doi: 10.1001/jamanetworkopen.2019.4428
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2019.4428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6632150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31125106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Evaluation%20of%20Cancer-Based%20Criteria%20for%20Use%20in%20Mainstream%20BRCA1%20and%20BRCA2%20Genetic%20Testing%20in%20Patients%20With%20Breast%20Cancer&amp;author=Z%20Kemp&amp;author=A%20Turnbull&amp;author=S%20Yost&amp;author=S%20Seal&amp;author=S%20Mahamdallie&amp;volume=2&amp;publication_year=2019&amp;pages=e194428&amp;pmid=31125106&amp;doi=10.1001/jamanetworkopen.2019.4428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Hamilton JG, Symecko H, Spielman K, Breen K, Mueller R, Catchings A, et al. Uptake and Acceptability of a Mainstreaming Model of Hereditary Cancer Multigene Panel Testing Among Patients With Ovarian, Pancreatic, and Prostate Cancer. Genet Med (2021) 23:2105â€“13. doi: 10.1038/s41436-021-01262-2
</cite> [<a href="https://doi.org/10.1038/s41436-021-01262-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8556289/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34257420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Uptake%20and%20Acceptability%20of%20a%20Mainstreaming%20Model%20of%20Hereditary%20Cancer%20Multigene%20Panel%20Testing%20Among%20Patients%20With%20Ovarian,%20Pancreatic,%20and%20Prostate%20Cancer&amp;author=JG%20Hamilton&amp;author=H%20Symecko&amp;author=K%20Spielman&amp;author=K%20Breen&amp;author=R%20Mueller&amp;volume=23&amp;publication_year=2021&amp;pmid=34257420&amp;doi=10.1038/s41436-021-01262-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD, 2nd, et al. Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer. J Clin Oncol (2010) 28:3570â€“6. doi: 10.1200/JCO.2009.27.2997
</cite> [<a href="https://doi.org/10.1200/JCO.2009.27.2997" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2917312/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20606085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Somatic%20Mutations%20in%20BRCA1%20and%20BRCA2%20Could%20Expand%20the%20Number%20of%20Patients%20That%20Benefit%20From%20Poly%20(ADP%20Ribose)%20Polymerase%20Inhibitors%20in%20Ovarian%20Cancer&amp;author=BT%20Hennessy&amp;author=KM%20Timms&amp;author=MS%20Carey&amp;author=A%20Gutin&amp;author=LA%20Meyer&amp;volume=28&amp;publication_year=2010&amp;pmid=20606085&amp;doi=10.1200/JCO.2009.27.2997&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, et al. Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas. Clin Cancer Res (2014) 20:764â€“75. doi: 10.1158/1078-0432.CCR-13-2287
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-2287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3944197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24240112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Germline%20and%20Somatic%20Mutations%20in%20Homologous%20Recombination%20Genes%20Predict%20Platinum%20Response%20and%20Survival%20in%20Ovarian,%20Fallopian%20Tube,%20and%20Peritoneal%20Carcinomas&amp;author=KP%20Pennington&amp;author=T%20Walsh&amp;author=MI%20Harrell&amp;author=MK%20Lee&amp;author=CC%20Pennil&amp;volume=20&amp;publication_year=2014&amp;pmid=24240112&amp;doi=10.1158/1078-0432.CCR-13-2287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Yost S, Ruark E, Alexandrov LB, Rahman N. Insights Into BRCA Cancer Predisposition From Integrated Germline and Somatic Analyses in 7632 Cancers. JNCI Cancer Spectr (2019) 3:pkz028. doi: 10.1093/jncics/pkz028
</cite> [<a href="https://doi.org/10.1093/jncics/pkz028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6649772/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31360904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JNCI%20Cancer%20Spectr&amp;title=Insights%20Into%20BRCA%20Cancer%20Predisposition%20From%20Integrated%20Germline%20and%20Somatic%20Analyses%20in%207632%20Cancers&amp;author=S%20Yost&amp;author=E%20Ruark&amp;author=LB%20Alexandrov&amp;author=N%20Rahman&amp;volume=3&amp;publication_year=2019&amp;pages=pkz028&amp;pmid=31360904&amp;doi=10.1093/jncics/pkz028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Vos JR, Fakkert IE, de Hullu JA, van Altena AM, Sie AS, Ouchene H, et al. Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition. J Natl Cancer Inst (2020) 112:161â€“9. doi: 10.1093/jnci/djz080
</cite> [<a href="https://doi.org/10.1093/jnci/djz080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7019087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31076742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Universal%20Tumor%20DNA%20BRCA1/2%20Testing%20of%20Ovarian%20Cancer:%20Prescreening%20PARPi%20Treatment%20and%20Genetic%20Predisposition&amp;author=JR%20Vos&amp;author=IE%20Fakkert&amp;author=JA%20de%20Hullu&amp;author=AM%20van%20Altena&amp;author=AS%20Sie&amp;volume=112&amp;publication_year=2020&amp;pmid=31076742&amp;doi=10.1093/jnci/djz080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Spizzo G, Puccini A, Xiu J, Goldberg RM, Grothey A, Shields AF, et al. Molecular Profile of BRCA-Mutated Biliary Tract Cancers. ESMO Open (2020) 5(5):e000682. doi: 10.1136/esmoopen-2020-000682
</cite> [<a href="https://doi.org/10.1136/esmoopen-2020-000682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7312328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32576609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESMO%20Open&amp;title=Molecular%20Profile%20of%20BRCA-Mutated%20Biliary%20Tract%20Cancers&amp;author=G%20Spizzo&amp;author=A%20Puccini&amp;author=J%20Xiu&amp;author=RM%20Goldberg&amp;author=A%20Grothey&amp;volume=5&amp;issue=5&amp;publication_year=2020&amp;pages=e000682&amp;pmid=32576609&amp;doi=10.1136/esmoopen-2020-000682&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Jalloul N, Gomy I, Stokes S, Gusev A, Johnson BE, Lindeman NI, et al. Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing. JCO Precis Oncol (2021) 5:PO.21.00279. doi: 10.1200/PO.21.00279
</cite> [<a href="https://doi.org/10.1200/PO.21.00279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8608266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34820595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCO%20Precis%20Oncol&amp;title=Germline%20Testing%20Data%20Validate%20Inferences%20of%20Mutational%20Status%20for%20Variants%20Detected%20From%20Tumor-Only%20Sequencing&amp;author=N%20Jalloul&amp;author=I%20Gomy&amp;author=S%20Stokes&amp;author=A%20Gusev&amp;author=BE%20Johnson&amp;volume=5&amp;publication_year=2021&amp;pages=PO.21.00279&amp;pmid=34820595&amp;doi=10.1200/PO.21.00279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Liu YL, Selenica P, Zhou Q, Iasonos A, Callahan M, Feit NZ, et al. BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer. JCO Precis Oncol (2020) 4:PO.20.00069. doi: 10.1200/PO.20.00069
</cite> [<a href="https://doi.org/10.1200/PO.20.00069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7446408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32923884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCO%20Precis%20Oncol&amp;title=BRCA%20Mutations,%20Homologous%20DNA%20Repair%20Deficiency,%20Tumor%20Mutational%20Burden,%20and%20Response%20to%20Immune%20Checkpoint%20Inhibition%20in%20Recurrent%20Ovarian%20Cancer&amp;author=YL%20Liu&amp;author=P%20Selenica&amp;author=Q%20Zhou&amp;author=A%20Iasonos&amp;author=M%20Callahan&amp;volume=4&amp;publication_year=2020&amp;pages=PO.20.00069&amp;pmid=32923884&amp;doi=10.1200/PO.20.00069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Harpaz N, Gatt YE, Granit RZ, Fruchtman H, Hubert A, Grinshpun A. Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer. J Oncol (2020) 2020:6421205. doi: 10.1155/2020/6421205
</cite> [<a href="https://doi.org/10.1155/2020/6421205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7196997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32377194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Oncol&amp;title=Mucinous%20Histology,%20BRCA1/2%20Mutations,%20and%20Elevated%20Tumor%20Mutational%20Burden%20in%20Colorectal%20Cancer&amp;author=N%20Harpaz&amp;author=YE%20Gatt&amp;author=RZ%20Granit&amp;author=H%20Fruchtman&amp;author=A%20Hubert&amp;volume=2020&amp;publication_year=2020&amp;pages=6421205&amp;pmid=32377194&amp;doi=10.1155/2020/6421205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Yeo ZX, Wong JC, Rozen SG, Lee AS. Evaluation and Optimisation of Indel Detection Workflows for Ion Torrent Sequencing of the BRCA1 and BRCA2 Genes. BMC Genomics (2014) 15:516. doi: 10.1186/1471-2164-15-516
</cite> [<a href="https://doi.org/10.1186/1471-2164-15-516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4079958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24962530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;title=Evaluation%20and%20Optimisation%20of%20Indel%20Detection%20Workflows%20for%20Ion%20Torrent%20Sequencing%20of%20the%20BRCA1%20and%20BRCA2%20Genes&amp;author=ZX%20Yeo&amp;author=JC%20Wong&amp;author=SG%20Rozen&amp;author=AS%20Lee&amp;volume=15&amp;publication_year=2014&amp;pages=516&amp;pmid=24962530&amp;doi=10.1186/1471-2164-15-516&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Ruiz A, Llort G, YagÃ¼e C, Baena N, ViÃ±as M, Torra M, et al. Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing. BioMed Res Int (2014) 2014:542541. doi: 10.1155/2014/542541
</cite> [<a href="https://doi.org/10.1155/2014/542541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4098986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25136594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioMed%20Res%20Int&amp;title=Genetic%20Testing%20in%20Hereditary%20Breast%20and%20Ovarian%20Cancer%20Using%20Massive%20Parallel%20Sequencing&amp;author=A%20Ruiz&amp;author=G%20Llort&amp;author=C%20Yag%C3%BCe&amp;author=N%20Baena&amp;author=M%20Vi%C3%B1as&amp;volume=2014&amp;publication_year=2014&amp;pages=542541&amp;pmid=25136594&amp;doi=10.1155/2014/542541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Poulet A, Privat M, Ponelle F, Viala S, Decousus S, Perin A, et al. Improved Efficiency and Reliability of NGS Amplicon Sequencing Data Analysis for Genetic Diagnostic Procedures Using AGSA Software. BioMed Res Int (2016) 2016:5623089. doi: 10.1155/2016/5623089
</cite> [<a href="https://doi.org/10.1155/2016/5623089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5021467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27656653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioMed%20Res%20Int&amp;title=Improved%20Efficiency%20and%20Reliability%20of%20NGS%20Amplicon%20Sequencing%20Data%20Analysis%20for%20Genetic%20Diagnostic%20Procedures%20Using%20AGSA%20Software&amp;author=A%20Poulet&amp;author=M%20Privat&amp;author=F%20Ponelle&amp;author=S%20Viala&amp;author=S%20Decousus&amp;volume=2016&amp;publication_year=2016&amp;pages=5623089&amp;pmid=27656653&amp;doi=10.1155/2016/5623089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Tao H, Liu S, Huang D, Han X, Wu X, Shao YW, et al. Acquired Multiple Secondary BRCA2 Mutations Upon PARPi Resistance in a Metastatic Pancreatic Cancer Patient Harboring a BRCA2 Germline Mutation. Am J Transl Res (2020) 12:612â€“7.</cite> [<a href="/articles/PMC7061843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32194909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Transl%20Res&amp;title=Acquired%20Multiple%20Secondary%20BRCA2%20Mutations%20Upon%20PARPi%20Resistance%20in%20a%20Metastatic%20Pancreatic%20Cancer%20Patient%20Harboring%20a%20BRCA2%20Germline%20Mutation&amp;author=H%20Tao&amp;author=S%20Liu&amp;author=D%20Huang&amp;author=X%20Han&amp;author=X%20Wu&amp;volume=12&amp;publication_year=2020&amp;pmid=32194909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>
Tobalina L, Armenia J, Irving E, Oâ€™Connor MJ. Forment J.V. A Meta-Analysis of Reversion Mutations in BRCA Genes Identifies Signatures of DNA End-Joining Repair Mechanisms Driving Therapy Resistance. Ann Oncol (2021) 32:103â€“12. doi: 10.1016/j.annonc.2020.10.470
</cite> [<a href="https://doi.org/10.1016/j.annonc.2020.10.470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33091561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Forment%20J.V.%20A%20Meta-Analysis%20of%20Reversion%20Mutations%20in%20BRCA%20Genes%20Identifies%20Signatures%20of%20DNA%20End-Joining%20Repair%20Mechanisms%20Driving%20Therapy%20Resistance&amp;author=L%20Tobalina&amp;author=J%20Armenia&amp;author=E%20Irving&amp;author=MJ%20O%E2%80%99Connor&amp;volume=32&amp;publication_year=2021&amp;pmid=33091561&amp;doi=10.1016/j.annonc.2020.10.470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>
Cunningham JM, Cicek MS, Larson NB, Davila J, Wang C, Larson MC, et al. Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status. Sci Rep (2014) 4:4026. doi: 10.1038/srep04026
</cite> [<a href="https://doi.org/10.1038/srep04026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4168524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24504028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Clinical%20Characteristics%20of%20Ovarian%20Cancer%20Classified%20by%20BRCA1,%20BRCA2,%20and%20RAD51C%20Status&amp;author=JM%20Cunningham&amp;author=MS%20Cicek&amp;author=NB%20Larson&amp;author=J%20Davila&amp;author=C%20Wang&amp;volume=4&amp;publication_year=2014&amp;pages=4026&amp;pmid=24504028&amp;doi=10.1038/srep04026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>
Hansmann T, Pliushch G, Leubner M, Kroll P, Endt D, Gehrig A, et al. Constitutive Promoter Methylation of BRCA1 and RAD51C in Patients With Familial Ovarian Cancer and Early-Onset Sporadic Breast Cancer. Hum Mol Genet (2012) 21:4669â€“79. doi: 10.1093/hmg/dds308
</cite> [<a href="https://doi.org/10.1093/hmg/dds308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3471399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22843497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet&amp;title=Constitutive%20Promoter%20Methylation%20of%20BRCA1%20and%20RAD51C%20in%20Patients%20With%20Familial%20Ovarian%20Cancer%20and%20Early-Onset%20Sporadic%20Breast%20Cancer&amp;author=T%20Hansmann&amp;author=G%20Pliushch&amp;author=M%20Leubner&amp;author=P%20Kroll&amp;author=D%20Endt&amp;volume=21&amp;publication_year=2012&amp;pmid=22843497&amp;doi=10.1093/hmg/dds308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>
Azzollini J, Pesenti C, Pizzamiglio S, Fontana L, Guarino C, Peissel B, et al. Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer. Cancers (Basel) (2019) 11:58. doi: 10.3390/cancers11010058
</cite> [<a href="https://doi.org/10.3390/cancers11010058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6356733/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30634417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Constitutive%20BRCA1%20Promoter%20Hypermethylation%20Can%20Be%20a%20Predisposing%20Event%20in%20Isolated%20Early-Onset%20Breast%20Cancer&amp;author=J%20Azzollini&amp;author=C%20Pesenti&amp;author=S%20Pizzamiglio&amp;author=L%20Fontana&amp;author=C%20Guarino&amp;volume=11&amp;publication_year=2019&amp;pages=58&amp;pmid=30634417&amp;doi=10.3390/cancers11010058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>
Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A Population-Based Study of Genes Previously Implicated in Breast Cancer. N Engl J Med (2021) 384:440â€“51. doi: 10.1056/NEJMoa2005936
</cite> [<a href="https://doi.org/10.1056/NEJMoa2005936" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8127622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20Population-Based%20Study%20of%20Genes%20Previously%20Implicated%20in%20Breast%20Cancer&amp;author=C%20Hu&amp;author=SN%20Hart&amp;author=R%20Gnanaolivu&amp;author=H%20Huang&amp;author=KY%20Lee&amp;volume=384&amp;publication_year=2021&amp;pmid=33471974&amp;doi=10.1056/NEJMoa2005936&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>
Breast Cancer Association Consortium. Dorling L, Carvalho S, Allen J, GonzÃ¡lez-Neira A, Luccarini C, et al. Breast Cancer Risk Genes - Association Analysis in More Than 113,000 Women. N Engl J Med (2021) 384:428â€“39. doi: 10.1056/NEJMoa1913948
</cite> [<a href="https://doi.org/10.1056/NEJMoa1913948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Breast%20Cancer%20Risk%20Genes%20-%20Association%20Analysis%20in%20More%20Than%20113,000%20Women&amp;author=L%20Dorling&amp;author=S%20Carvalho&amp;author=J%20Allen&amp;author=A%20Gonz%C3%A1lez-Neira&amp;author=C%20Luccarini&amp;volume=384&amp;publication_year=2021&amp;pmid=33471991&amp;doi=10.1056/NEJMoa1913948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>
Coignard J, Lush M, Beesley J, Oâ€™Mara TA, Dennis J, Tyrer JP, et al. A Case-Only Study to Identify Genetic Modifiers of Breast Cancer Risk for BRCA1/BRCA2 Mutation Carriers. Nat Commun (2021) 12:1078. doi: 10.1038/s41467-020-20496-3
</cite> [<a href="https://doi.org/10.1038/s41467-020-20496-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7890067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33597508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=A%20Case-Only%20Study%20to%20Identify%20Genetic%20Modifiers%20of%20Breast%20Cancer%20Risk%20for%20BRCA1/BRCA2%20Mutation%20Carriers&amp;author=J%20Coignard&amp;author=M%20Lush&amp;author=J%20Beesley&amp;author=TA%20O%E2%80%99Mara&amp;author=J%20Dennis&amp;volume=12&amp;publication_year=2021&amp;pages=1078&amp;pmid=33597508&amp;doi=10.1038/s41467-020-20496-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplementary FigureÂ 1</span><p>Age at diagnosis of ovarian cancer in patients with confirmed germline vs. somatic only BRCA pathogenic/likely pathogenic variants (PVs). The median age is indicated by the horizontal lines; eligibility to germline testing according to the empirical criteria used at our Institution is indicated for eachÂ patient.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9026437/bin/Image_1.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (167.3KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9026437/bin/Table_1.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (12KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9026437/bin/Table_2.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (12.6KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Oncology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fonc.2022.857515"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fonc-12-857515.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (934.0Â KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9026437/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9026437/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9026437%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9026437/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9026437/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9026437/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35463374/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9026437/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35463374/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9026437/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9026437/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="1ikBkGez7mZGNyjlgg3ZAcgMFOp5bhMWDsKO6yH7o4t0YEOmwfrz7k9sMGOie2hr">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
